international market

hansoh actively implements the internationalization strategy and has been committed itself to human being’s health with its professional expertise, through sales of internationally certified apis and finished-dose pharmaceutical products to  the u.s. and other countries, and  international multi-center clinical trials for innovative drugs.   

market internationalization 

multiple finished-dose pharmaceutical products and apis are sold to the global market. 

r&d internationalization

global multi-center clinical trials are under way simultaneously in the u.s. and china for hs-10296, a category 1.1 innovative oncology drug, amid efforts for global expansion of innovative drugs.